Radiotherapy (RT), including external beam RT and internal radiation therapy, uses high-
energy ionizing radiation to kill tumor cells. However, ionizing radiation inevitably damages …

Recent advances in technology are expected to increase our current understanding of
neuroscience. Nanotechnology and nanomaterials can alter and control neural functionality …

Simple Summary Glioblastoma (GBM) is a common primary brain tumor with a short median
overall survival despite aggressive treatment with resection, chemotherapy, and radiation …

Glioblastoma is one of the most aggressive central nervous system malignancies with high
morbidity and mortality. Current clinical approaches, including surgical resection …

In recent years, nano-based drug delivery systems have gradually been regarded as a
promising approach to improve the current glioblastoma treatment, attracting many …

Because of their moderate penetration power, β-rays (high-energy electrons) are a useful
signal for evaluating the surface contamination of nuclear radiation. However, the …

Radiotherapy and internal radioisotope therapy (brachytherapy) induce tumor cell death
through different molecular signaling pathways. However, these therapies in cancer patients …

Glioblastoma is the most common primary, malignant brain tumor that remains uniformly
lethal in nearly all cases as a result of extreme cellular heterogeneity, treatment resistance …

Glioblastoma multiforme is one of the most common and malignant types of central nervous
system (CNS) tumors. Despite the great advances in treatment modalities and the variety of …

Radiotherapy (RT) is the established noninvasive treatment for glioblastoma (GBM), a highly
aggressive malignancy. However, its effectiveness in improving patient survival remains …